We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+8.87%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$430B
AUM Growth
+$52.2B
Cap. Flow
+$21.8B
Cap. Flow %
5.08%
Top 10 Hldgs %
15.82%
Holding
7,012
New
186
Increased
4,119
Reduced
1,891
Closed
188

Top Buys

Rank Stock Value
1
UBER icon
Uber
UBER
+$914M
2
OKTA icon
Okta
OKTA
+$823M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$687M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$647M
5
T icon
AT&T
T
+$636M

Sector Composition

Rank Sector Weight
1 Technology 15.05%
2 Healthcare 10.24%
3 Financials 9.62%
4 Communication Services 7.72%
5 Consumer Discretionary 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBOT icon
5726
Microbot Medical
MBOT
$116M
$42K ﹤0.01%
4,087
-286
-7% -$1.68K
OEFA
5727
ALPS O'Shares International Developed Quality Dividend ETF
OEFA
$36.5M
$42K ﹤0.01%
1,644
-450
-21% -$11.1K
CYTO
5728
DELISTED
Altamira Therapeutics Ltd
CYTO
$42K ﹤0.01%
65
+34
+110% +$23K
AXLA
5729
DELISTED
Axcella Health Inc. Common Stock
AXLA
$42K ﹤0.01%
418
+397
+1,890% +$43.6K
BRMK
5730
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$42K ﹤0.01%
+3,259
New +$36.2K
PBBI
5731
DELISTED
PB Bancorp, Inc. Common Stock
PBBI
$42K ﹤0.01%
2,757
GSH
5732
DELISTED
Guangshen Railway Co. Ltd
GSH
$42K ﹤0.01%
2,552
+197
+8% +$3.18K
BLOK icon
5733
Amplify Blockchain Technology ETF
BLOK
$1.08B
$41K ﹤0.01%
2,152
+196
+10% +$3.61K
GB
5734
DELISTED
Global Blue Group Holding
GB
$41K ﹤0.01%
3,949
+1,143
+41% +$11.7K
PVL
5735
Permianville Royalty Trust
PVL
$57.1M
$41K ﹤0.01%
22,154
+5,100
+30% +$10.1K
XOMA
5736
DELISTED
Xoma
XOMA
$41K ﹤0.01%
1,501
+1,013
+208% +$22.7K
OTTW
5737
DELISTED
Ottawa Bancorp, Inc. Common Stock
OTTW
$41K ﹤0.01%
3,000
-119
-4% -$1.62K
CORV
5738
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$41K ﹤0.01%
99,852
+56,395
+130% +$93.7K
USLB
5739
DELISTED
Invesco Russell 1000 Low Beta Equal Weight ETF
USLB
$41K ﹤0.01%
1,174
HYGH icon
5740
iShares Interest Rate Hedged High Yield Bond ETF
HYGH
$593M
$40K ﹤0.01%
449
-20
-4% -$1.77K
NUMV icon
5741
Nuveen ESG Mid-Cap Value ETF
NUMV
$444M
$40K ﹤0.01%
1,308
BPTH
5742
DELISTED
Bio-Path Holdings Inc
BPTH
$40K ﹤0.01%
249
+148
+147% +$27.8K
AMBC.WS
5743
DELISTED
Ambac Financial Group
AMBC.WS
$40K ﹤0.01%
4,069
-2,502
-38% -$23K
ZN
5744
DELISTED
Zion Oil & Gas, Inc.
ZN
$40K ﹤0.01%
232,902
-17,664
-7% -$3.45K
BDCL
5745
DELISTED
2Leveraged Long ETRACS Linked to the Wells Fargo Business Dev
BDCL
$40K ﹤0.01%
2,680
AYTU icon
5746
AYTU BioPharma
AYTU
$23.9M
$39K ﹤0.01%
+199
New +$38.2K
BH.A icon
5747
Biglari Holdings Class A
BH.A
$1.25B
$39K ﹤0.01%
64
-12
-16% -$6.3K
KNG icon
5748
FT Vest S&P 500 Dividend Aristocrats Target Income ETF
KNG
$3.4B
$39K ﹤0.01%
+850
New +$38.4K
MTNB icon
5749
Matinas BioPharma
MTNB
$1.88M
$39K ﹤0.01%
+346
New +$20K
VUZI icon
5750
Vuzix
VUZI
$194M
$39K ﹤0.01%
19,169
-6,142
-24% -$13.9K

Similar funds

Morgan Stanley's Q4 2019 Portfolio in Review

As of Q4 2019, Morgan Stanley held 7,012 positions worth $430B, up 14% from $378B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Morgan Stanley deployed $21.8B of net new capital in Q4 2019, opening 186 new positions and adding to 4,119 existing holdings. Its largest new stake was XChange TEC: 50 shares worth $44M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.24B trimmed.

  • Morgan Stanley's largest Q4 2019 buy was XChange TEC: 50 shares worth $44M.
  • Morgan Stanley added most to Uber in Q4 2019, an estimated $914M increase.
  • Morgan Stanley's biggest Q4 2019 reduction was iShares Russell 2000 ETF, cutting an estimated $1.24B.
  • Morgan Stanley fully exited Buckeye Partners, L.P. in Q4 2019, selling an estimated $505M.
  • Morgan Stanley's ten largest holdings make up 16% of its $430B portfolio in Q4 2019.
  • Morgan Stanley opened 186 new positions and closed 188 in Q4 2019.
  • Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $430B.

Based on Morgan Stanley's 13F filing for Q4 2019, filed 14 Feb 2020.